Burkina Faso NITAG recommendation on the introduction of nOPV2 vaccine in response to type2 vaccine-derived poliomyelitis outbreaks

With a view of using the nOPV2 vaccine and in accordance with its mandate, the NITAG initiated an informed opinion on the use of nOPV2 in vaccine responses to outbreaks of cVDPV2.